Pune Gas Continues its Nationwide Expansion with a Fifth Experience Centre
Pune Gas, India's leading name in commercial and industrial gas systems and…
OSE Immunotherapeutics met jour linformation sur les procdures en cours
OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2,…
Zurich Kotak General Insurance marks its First Foundation Day with a Commitment to its Community and Commercial Insurance Launch
MUMBAI, India, June 23, 2025 /PRNewswire/ --Â Zurich Kotak General Insurance (Zurich Kotak)…
CEA Opens ShanghaiAucklandBuenos Aires “New International Land-Sea Trade Corridor” to First Bridge China and South America
SHANGHAI--(BUSINESS WIRE)--On June 18, 2025, China Eastern Airlines (CEA) and Auckland Airport…
Build a Prosperous F5.5G All-Optical Network Industry for New Growth in the AI Era
SHANGHAI, June 19, 2025 /PRNewswire/ -- During MWC Shanghai 2025, the F5.5G…
Tata Elxsi and Infineon Partner to Accelerate EV Innovation in India
Collaboration focuses on ready-to-deploy EV systems built on Infineon technologies for two-wheelers…
Next-Gen Edge AI Solutions for the Real World: Autonomous Navigation for Drones, Surveillance and Robotics
IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX),…
ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025
EINDHOVEN, the Netherlands, June 17, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V.…
Sunny Mining achieves breakthrough AI-driven technology,Becoming a profitable milestone in the cloud mining industry
San Francisco County, California , June 13, 2025 (GLOBE NEWSWIRE) -- Recently,…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients](https://i1.wp.com/ml-eu.globenewswire.com/media/NTJlMDkyZjktNGMwNi00N2YyLTkyZmQtZTIwMWJlNzgxOWYyLTEwMTI2MjEtMjAyNS0wNi0xNS1lbg==/tiny/F-Hoffmann-La-Roche-Ltd.png?w=420&resize=420,280&ssl=1 "[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients")
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
After a thorough clinical review, the benefit-risk for the use of Elevidys…